Neidio i'r cynnwys
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Iaith
Pob Maes
Teitl
Awdur
Pwnc
Rhif Galw
ISBN/ISSN
Tag
Canfod
Uwch
Inability to Tolerate Standard...
Dyfynnu hwn
Anfonwch hwn fel neges destun
E-bostio hwn
Argraffu
Allforio Cofnod
Allforio i RefWorks
Allforio i EndNoteWeb
Allforio i EndNote
Permanent link
Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial
Show other versions (2)
Manylion Llyfryddiaeth
Prif Awduron:
Sive, J
,
Buck, G
,
Fielding, A
,
Lazarus, H
,
Litzow, MR
,
Luger, S
,
Marks, D
,
McMillan, A
,
Richards, S
,
Rowe, J
,
Tallman, MS
,
Goldstone, A
Fformat:
Conference item
Cyhoeddwyd:
2010
Daliadau
Disgrifiad
Other Versions (2)
Eitemau Tebyg
Dangos Staff
Eitemau Tebyg
Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial
gan: Sive, J, et al.
Cyhoeddwyd: (2010)
Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial
gan: Sive, J, et al.
Cyhoeddwyd: (2010)
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.
gan: Sive, J, et al.
Cyhoeddwyd: (2012)
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.
gan: Fielding, A, et al.
Cyhoeddwyd: (2007)
Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial
gan: Fielding, A, et al.
Cyhoeddwyd: (2010)